BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 2, 2015
View Archived Issues
Otonomy submits NDA to the FDA for AuriPro
Read More
Abivax recruits first patient in pivotal phase IIb/III trial of ABX-203
Read More
ReveraGen awarded grant to fun development of VBP-15 for Duchenne muscular dystrophy
Read More
Rosetta Genomics updates development progress of microRNA-based thyroid neoplasia assay
Read More
Phase II trial initiated of Aduro Biotech's GVAX Pancreas and CRS-207 in combination with nivolumab
Read More
Amarin and Eddingpharm sign Vascepa agreement for China
Read More
Bovine lactoferrin receives two FDA orphan designations
Read More
Triphase Accelerator and Sunnybrook Research Institute to collaborate on TRPH-011
Read More
Merck Patent discloses new fatty acid synthase inhibitors
Read More
German organization patents GRK5 modulators
Read More
Gruenenthal patent reports new CRAC inhibitors
Read More
New MEK inhibitors patented by Novartis
Read More
Scientists at ICGEB disclose anti-dengue virus vaccine
Read More
Lenvima now available in U.S.
Read More
Inhibition of HIV RNA biogenesis blocks viral replication and avoids viremia rebound
Read More
CHMP recommends conditional marketing approval of ceritinib
Read More
EMA's CHMP backs approval of Jinarc for rare kidney disease
Read More
EMA committee recommends new approval of Vectibix in metastatic colorectal cancer
Read More
FDA postpones meeting to discuss a BLA for Celltrion's CT-P13
Read More
Combination therapy shows efficiency for HIV/HCV coinfection treatment
Read More
Takeda withdraws new European Rienso submission
Read More
ENDEAVOR trial shows superiority of Kyprolis over Velcade in relapsed multiple myeloma
Read More
EMA accepts MAA for Santen's intravitreal sirolimus for non-infectious uveitis
Read More
Ibalizumab receives FDA breakthrough therapy designation
Read More
Rare Disease Day 2015: Focus on new means of developing treatments
Read More